Palisade Capital Management

Palisade Capital Management, LLC is a Fort Lee, NJ based Registered Investment Adviser that manages assets for institutions and high net worth individuals in a variety of product and service offerings. Every day we strive to preserve and enhance wealth by seeking consistent and superior risk-adjusted performance. We believe that anticipation of clients' needs, responsiveness to their requests, and furthering their understanding of our approach is critical to long-term successful relationships.

Steven E. Berman

Partner

Michael Chizmar

Vice President of Convertible Securities

Feiler, Michael Ian

VP Private Wealth Management

Frank Galdi

Partner, Deputy Chief Investment Officer and Chief Risk Officer

Claudio Giurgiu

Managing Director and CTO

Roseanne Heffernan

Assistant Vice President-Client Relations, Private Wealth Management

Kavanaugh, Kyle M.

Associate Portfolio Manager and Senior Vice President

Andrew Lakind

Vice President and Portfolio Analyst

William Lee

Partner, Convertible Strategies and Senior Portfolio Manager

Garo Norian

Senior Vice President of Research

Oh, Sammy

Managing Director and Senior Portfolio Manager

Bernard Picchi

Managing Director Private Wealth Management

Wendy S. Popowich

Managing Director of Private Wealth Management

William L. Potter

Managing Director and Senior Portfolio Manager

Lorraine Salvo

Managing Director, Private Wealth Management and Head of Financial Planning

Beata Tannuzzo

Partner and CFO, Finance

Veru, Dennison Theodore

Chief Investment Officer

Jeffrey Weekes

Associate, Private Equity

10 past transactions

ElMindA

Series C in 2015
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.

Brickell Biotech

Series B in 2013
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell’s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®.

Neurologix

Venture Round in 2010
Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The company's treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinson's disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitive, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntington's disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey.

Send Word Now

Series D in 2008
Send Word Now is the worldwide provider of enterprise communications services. Their easy-to-use, web-based and mobile solutions are deployed by businesses, government agencies, universities and non-profit organizations to ensure fast, effective communication when it is needed the most. Send Word Now was founded in 2001, by a group of individuals who recognized the need for immediate, reliable and multimodal crisis communications after the tragedies of September 11, 2001. Since that time, organizations across the globe have faced a multitude of natural and man-made disruptions, creating a heightened focus on business continuity, regulatory compliance, security and the ability to audit information flow. Further, today’s borderless business environment and increasingly mobile workforce have surfaced new needs for operations-focused communication and collaboration. Send Word Now is successfully transforming the way organizations communicate globally, both for emergency situations, and for every day, time-sensitive interactions. Their enterprise-class emergency notification system is capable of transmitting tens of thousands of voice and text messages in minutes, while providing a full audit trail for after action reporting and follow-up. Their mobile conferencing, collaboration and workflow solutions keep employees informed and connected to the people and information they need. And, everything is backed by their 100% Uptime reliability guarantee, and unmatched 24x7x365 customer support. In emergencies, or every day. When rapid, effective communication is essential for success, rely on Send Word Now for innovative, secure and reliable notification and collaboration solutions.

Mitralign

Series C in 2007
Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening. Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.

Shoe Sensation

Private Equity Round in 2007
Shoe Sensation is a regional chain of family shoe stores selling quality name-brand shoes. Their stores carry a large selection of men's, women's, children's, and athletic footwear in a better-branded merchandise mix. Shoe Sensation was developed to meet the footwear needs of the entire family; their clientele range from toddlers to senior citizens.

Ikonisys

Series E in 2007
Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease.

Language Weaver

Series B in 2004
Language Weaver, Inc., a human communication solutions company, develops and licenses automated translation solutions for multinationals, government organizations, and translation providers. The company focuses on automated language translation. It offers LW Enterprise Translation Server, an on-site software for language translation within a enterprise; LW Custom Enterprise Translation Server for translations in a specific domain, such as information technology, automotive, medical, and finance; and LW Translation On Demand, an on demand translation service. The company also provides LW Custom Translation On Demand, an on demand translation service hosted on a dedicated server by Language Weaver; and LW Professional Services, which include software training, custom language pair development, and preparation of parallel data.

Achieve3000

Series B in 2004
Achieve3000 delivers differentiated literacy solutions proven to increase reading comprehension and fluency, vocabulary and writing proficiency for students in grades 2 through 12. Through its proprietary software engine, the company uses the Internet to provide each student with an appropriate version of the same content based on his or her reading level. The company's products include KidBiz3000 (a reading and writing program for grades 2 through 5), TeenBiz3000 (a reading and writing program for grades 6 through 12) and Spark3000® (a reading and writing program for adult learners).

Versura

Venture Round in 2001
Versura is an online education-loan exchange.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.